Salivary Antioxidant Capacity in Graft versus Host Disease

REFERENCES

• Thomas E. D. Bone marrow transplantation: a review. Semin. Hematol. 1999; 36: 95–103, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Schmitz N., Beksac M., Hasenclever D., Bacigalupo A., Ruutu T., et al. Eurpean group for blood and marrow transplantation. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002; 100(3)761–767, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Billingham R. E. The biology of graft-versus-host reactions. Harvey Lect. 1966; 62: 21–78, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Korngold R., Sprent J. Graft-versus-host disease in experimental allogeneic bone marrow transplantation. Proc. Soc. Exp. Biol. Med. 1991; 197: 12–18, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Krenger W., Ferrara J. L. Graft-versus host disease and the TH1/Th2 paradigm. Immonol. Res. 1996; 15: 50–73, [CSA]
   PubMed Web of Science ®Google Scholar
• Storb R. Prevention of graft-versus-host disease after bone marrow transplantation. Transplant. Proc. 1995; 27: 2653–2656, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hirozane A., Fujikura Y., Sawada T., Shinozaki F., Fukumoto T. Analysis of major histocompatibility complex (MHC) class 1 antigen in the rat salivary gland. Arch. Oral. Biol. 1992; 37: 147–151, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nagler R. M., Laufer D., Nagler A. Parotid gland dysfunction in a murine model of acute graft versus host disease [GVHD]. Head Neck 1998; 20: 58–62, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nagler R., Marmary Y., Krausz Y., Chisin R., Markitziu A., Nagler A. Major salivary gland dysfunction in human acute and chonic graft-versus-host disease (GVHD). Bone Marrow Transplant. 1996; 219–224, [CSA]
   PubMed Web of Science ®Google Scholar
• Nagler R. M., Laufer D., Nagler A. Parotid gland dysfunction in an animal model of chronic graft-vs-host disease. Arch. Otolaryngol. Head Neck Surg. 1996; 1057–1060, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nagler A., Nagler R., Acherstein A., Levi S., Marmary Y. Major salivary gland dysfunction in patients with hematological malignancies receiving interleukin-2-based immunotherapy post-autologous blood stem cell transplantation (ABSCT). Bone Narrow Transplant. 1997; 575–580, [CROSSREF], [CSA]
   Google Scholar
• Lindahl G., Lonnquist B., Hedfors E. Lymphocytic infiltration and HLA-DR expression of salivary glands in bone marrow transplant recipients: a prospective study. Clin. Exp. Immunol. 1998; 267–273, [CSA]
   Google Scholar
• Levy S., Nagler A., Okon S., Marmary Y. Parotid salivary gland dysfunction in chronic fraft-versus-host disease (GVHD): a longitudinal study in a mouse model. Bone Marrow Transplant. 2000; 1073–1078, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hiroki A., Nakamura S., Shinohara M., Gondo H., Ohyama Y., Hayashi S., Harada M., Niho Y., Oka M. A comparison of glandular involvement between chronic graft-versus-host disease and Sjorgren's syndrome. Int. J. Oral Maxillofac. Surg. 1996; 298–307, [CSA]
   PubMed Web of Science ®Google Scholar
• Izutsu K. T., Sullivan K. M., Schubert M. M., Truelove E. L., Shulman H. M., Sale G. E., Morton T. H., Rice J. C., Witherspoon R. P., Storb R., Thomas E. D. Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease. Transplantation 1983; 441–446, [CSA]
   PubMed Web of Science ®Google Scholar
• Nakhleh R. E., Miller W., Snover D. C. Significance of mucosal vs salivary gland changes in lip biopsies in the diagnosis of chronic graft-vs-host disease. Arch. Pathol. Lab Med. 1989; 113: 932–934, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gaziev D., Galimberti M., Lucarelli G., Polclhi P. Chronic graft-versus-host disease: is there an alternative to the conventional treatment?. Bone Marrow Transplant. 2000; 25: 689–696, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kolbinson D. A., Schubert M. M., Flournoy N., Truelove E. L. Early oral changes following bone marrow transplantation. Oral Surg. Moral Med. Oral Pathol. 1988; 66: 130–138, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Nakamura S., Hiroki A., Shinohara M., Gondo H., Ohyama Y., Mouri T., Sasaki M., Shirasuna K., Harada M., Niho Y. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1996; 82: 556–563, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Barrett A. P., Bilous A. M. Oral patterns of acute and chronic graft-v-host disease. Arch. Dermatol. 1984; 120: 461–1465, [CROSSREF], [CSA]
   Google Scholar
• Nagler R. M., Nagler A. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study. Bone Marrow Transplant. 1999; 23: 100–1011, [CROSSREF], [CSA]
   Google Scholar
• Schubert M. M., Sullivan K. M., Morton T. H., Izutsu K. T., Peterson D. E., Flournoy N., Truelove E. L., Sale G. E., Buckner C. D., Storb R. Oral manifestations of chronic graft-v-host disease. Arch Intern. Med. 1984; 1591–1595, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Elad S., Or R., Garfunkel A. A., Shapira M. Y. Budesonide: a novel treatment for oral chronic graft versus host disease. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2003; 308–311, [CSA]
   PubMed Web of Science ®Google Scholar
• Nagler R. M., Kitrossky N., Chevion M. Antioxidant activity of rat parotid saliva. Arch. Otolaryngol. Head Neck Surg. 1997; 123(9)989–993, [CSA]
   PubMed Web of Science ®Google Scholar
• Diab-Ladki R., Pellat B., Chahine R. Decrease in the total antioxidant activity of saliva in patients with periodontal diseases. Clin. Oral Investig. 2003; 7: 103–107, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Nagler R. M., Klein I., Zarzhevsky N., Drigues N., Reznick A. Z. Characterization of the differentiated antioxidant profile of human saliva. Free Radic. Biol. Med. 2002; 32: 268–277, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Przepiorka D., Weisdorf D., Martin P., Klingmann G. H., Beatty P., Hows J., Thomas E. D. Consensus Conference on Acute VHD Grading. Bone Marrow Transplant 1995; 15: 825–828, [CSA]
   PubMed Web of Science ®Google Scholar
• Shulman H. M., Sullivan K. M., Weiden P. L., McDonald G. B., Striker G. E., Sale G. E., Hackman R., Tsoi M. S., Storb R., Thomas E. D. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am. J. Med. 1980; 69: 204–217, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffiusion. Immunochemistry 1965; 2: 235–254, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275, [CSA]
   PubMed Web of Science ®Google Scholar
• Pruitt K. M., Kamau D. N., Miller K., Mansson-Rahemtulla B., Rahemtulla F. Quantitative, standardized assays for determining the concentrations of bovine lactoperoxidase, human salivary peroxidase, and human myeloperoxidase. Anal. Biochem. 1990; 191: 278–286, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fossati P., Prencipe L., Berti G. Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serus and urine. Clin. Chem. 1980; 26: 227–231, [CSA]
   PubMed Web of Science ®Google Scholar
• Hiroki A., Nakamura S., Shinohara M., Oka M. Significance of oral examination in Chronic graft-versus-host disease—a prolonged study. Cancer Invest. 2003; 23: 34–40, [CSA]
   Google Scholar
• Nagler R. M., Nagler A. Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease—a prolonged study. Cancer Invest. 2003; 212: 34–40, [CROSSREF], [CSA]
   Google Scholar
• Jensen S. B., Pedersen A. M., Reibel J., Nauntofte B. Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer 2003; 11: 199–200, [CSA]
   PubMedGoogle Scholar
• Laine P., Meurman J. H., Tenovuo J., Murtomaa H., Lindqvist C., Pyrhonen S., Teerenhovi L. Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs. Eur. J. Cancer B. Oral. Oncol. 1992; 28B: 125–128, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Izutsu K. T., Menard T. W., Schubert M. M., Ensign W. Y., Sullivan K., Truelove E. L., Thomas E. D. Graft versus host disease-related secretory immunoglobulin A deficiency in bone marrow transplant recipients. Findings in labial saliva. Lab. Invest. 1985; 52: 292–297, [CSA]
   PubMed Web of Science ®Google Scholar
• Nagler R. M., Nagler A. The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease. Arch. Oral. Biol. 2001; 46: 689–695, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Norhagen-Engstrom G., Hammarstrom L., Lonnqvist B., Soder P. O., Smith C. I. Ontogency of immunoglobulins in bone marrow-transplanted individuals. An analysis of serum and salivary levels. Transplantation 1998; 46: 710–715, [CSA]
   Google Scholar
• Mills E. E. The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositits. Br. J. Cancer 1998; 57: 416–417, [CSA]
   Google Scholar
• Wadleigh R. G., Redman R. S., Graham M. L., Krasnow S. H., Anderson A., Cohen M. H. Vitamin E in the treatment of chemotherapy-induced mucositis. Am. J. Med. 1992; 92: 481–484, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lopez I., Goudou C., Ribrag V., Sauvage C., Hazebroucq G., Dreyfus F. Treatment of mucositis with vitamin E during administration of neutropenic antineoplastic agents. Ann. Med. Interne. (Paris) 1994; 145: 405–408, [CSA]
   PubMedGoogle Scholar
• Osaki T., Ueta E., Yoneda K., Hirota J., Yamamoto T. Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) wit other antioxidants. Head Neck. 1994; 16: 331–339, [CSA]
   PubMed Web of Science ®Google Scholar
• Santini V., Giles F. J. The potential of amifostine: from cytoprotectant to therapeutic agent. Haematologica 1999; 84: 1035–1042, [CSA]
   PubMed Web of Science ®Google Scholar
• Rezvani M., Ross G. A. Modification of radiation-induced acute oral mucositis in the rat. Int. J. Radiat. Biol. 2004; 80: 177–182, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nagler R., Marmary Y., Golan E., Chevion M. Novel protection strategy against X-ray induced damage to salivary glands. Radiat. Tes. 1998; 149: 271–276, [CSA]
   PubMed Web of Science ®Google Scholar
• Bourhis J., Rosine D. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma. Semin Oncol. 2002; 29: 61–62, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Duncan M., Grant G. Oral and Intestinal mucosistis-causes and possible treatments. Aliment Pharmacol Ther. 2003; 18: 853–874, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bergman V., Leanderson P., Starkhammar H. Urinary excretion of 8-hydroxydeoxyguanosine and malondialdehyde after high dose radiochemotherapy prededing stem cell transplantation. Free Radic. Biol. Med. 2004; 36: 300–306, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• High K. P., Legault C., Sinclair J. A., Cruz J., Hill K., Hurd D. D. Low plasma concentrations of retinol and alpha-tocopherol in hematopoietic stem cell transplant recipients: the effect of mucosistis and the risk of infection. Am. J. Clin. Nutr. 2002; 6(6)1358–1366, [CSA]
   Google Scholar
• Mohty M., Kuentz M., Michallet M., Bourhis J. H., Milpied N., Sutton L., Jouet J. P., Attal M., Bordigoni P., Cahn J. Y., Boiron J. M., Blaise D. Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC). Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 2002; 100(9)3128–3134, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bensinger W. I., Martin P. J., Storer B., Clift R., Forman S. J., Negrin R., Kashyap A., Flowers M. E., Lilleby K., Chauncey T. R., Storb R., Appelbaum F. R. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N. Engl. J. Med. 2001; 344(3)175–181, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar